Clinical Trials Browser

Phase 1/2 × OTHER × COVID-19 × Clear all

NCT04565665 2026-03-10

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase 1/2 Recruiting

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05273541 2022-04-18

Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer

Phase 1/2 Unknown

COVID-19